Trending: CVS Reports Strong Revenue in 3Q, Cuts Guidance
02 November 2023 - 1:54AM
Dow Jones News
10:24 ET -- CVS is one of the most mentioned companies in the
U.S. across all news items in the last 12 hours, according to
Factiva data. The healthcare giant reported third-quarter revenue
of $89.76 billion and earnings of $1.75 a share, surpassing the
expectations of analysts polled by FactSet. However, CVS dropped
its guidance range for 2023 EPS to $6.37 to $6.61 a share, citing
headwinds in key business segments. Dow Jones & Co. owns
Factiva. (susan.solan@wsj.com)
(END) Dow Jones Newswires
November 01, 2023 10:39 ET (14:39 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Dec 2024 to Jan 2025
CVS Health (NYSE:CVS)
Historical Stock Chart
From Jan 2024 to Jan 2025